Status:
UNKNOWN
Angiotensin Converting Enzyme rs (1799752) Gene Polymorphism and Development of In-Stent Restenosis in Patients With Stable Coronary Artery Diseases in Sohag Hospital University.
Lead Sponsor:
Sohag University
Conditions:
Angiotensin Converting Enzyme rs (1799752) Gene Polymorphism and Development of In-Stent Restenosis in Patients With Stable Coronary Artery Diseases
Eligibility:
All Genders
20-70 years
Brief Summary
One of the most common medical approaches to the treatment of coronary artery disease (CAD) is the percutaneous coronary intervention (PCI) which became frequent due to high efficiency and safety of th...
Eligibility Criteria
Inclusion
- patients with CAD
Exclusion
- PATIENTS WITHOUT OTHER HEALTH PROBLEMS
Key Trial Info
Start Date :
October 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
182 Patients enrolled
Trial Details
Trial ID
NCT06055673
Start Date
October 1 2023
End Date
December 1 2023
Last Update
September 28 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag university Hospital
Sohag, Egypt, Sohag